Taiwan-based vaccine maker Adimmune Corp. on Tuesday said it has signed an agreement with the World Health Organization (WHO) to receive early biological samples of emerging influenza variants.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Science & Tech
Taiwan study shows new system slashes crab roadkill
05/15/2025 05:10 PM - Sports
Taiwan's Yang, Liu advance to Thailand Open men's doubles quarterfinals
05/15/2025 05:02 PM - Society
Man arrested after brandishing chainsaw in Tainan convenience store
05/15/2025 04:58 PM - Society
Taiwan doctors help restore Eswatini teen's eyesight
05/15/2025 04:53 PM - Politics
Polish defense experts urge Taiwan to raise defense budget
05/15/2025 04:39 PM